SEC Form 4 · accession 0001140361-26-034066
Roivant Sciences Ltd. · ROIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mayukh Sukhatme
Officer — President & CIO · Director
Period of report
Aug 19, 2026
Accepted (ET)
Aug 21, 2026 · 9:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001635088
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 19, 2026 | M | 172,899 | $3.85 | A | 18,803,638 | D | |
| Common SharesF1 | Aug 19, 2026 | S | 172,899 | $37.17 | D | 18,630,739 | D | |
| Common Shares | Aug 20, 2026 | M | 17,519 | $3.85 | A | 18,648,258 | D | |
| Common SharesF2 | Aug 20, 2026 | S | 17,519 | $37.30 | D | 18,630,739 | D | |
| Common Shares | Aug 21, 2026 | M | 144,756 | $3.85 | A | 18,775,495 | D | |
| Common SharesF3 | Aug 21, 2026 | S | 144,756 | $36.48 | D | 18,630,739 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $3.85 | Aug 19, 2026 | M | 172,899 | D | — | Apr 19, 2032 | Common Shares | 172,899 | 13,386,638 | D |
| Stock Option (Right to Buy)F4 | $3.85 | Aug 20, 2026 | M | 17,519 | D | — | Apr 19, 2032 | Common Shares | 17,519 | 13,369,119 | D |
| Stock Option (Right to Buy)F4 | $3.85 | Aug 21, 2026 | M | 144,756 | D | — | Apr 19, 2032 | Common Shares | 144,756 | 13,224,363 | D |
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $37.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.20 to $37.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F4Award of stock options to purchase Common Shares that is fully vested.